Cancel anytime
Sabra Healthcare REIT Inc (SBRA)
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- PASS (Skip invest)*
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
11/27/2024: SBRA (4-star) is a STRONG-BUY. BUY since 142 days. Profits (34.50%). Updated daily EoD!
Analysis of Past Performance
Type: Stock | Upturn Star Rating | Today’s Advisory: Regular Buy |
Historic Profit: 43.1% | Upturn Advisory Performance 3 | Avg. Invested days: 61 |
Profits based on simulation | Stock Returns Performance 3 | Last Close 11/27/2024 |
Type: Stock | Today’s Advisory: Regular Buy |
Historic Profit: 43.1% | Avg. Invested days: 61 |
Upturn Star Rating | Stock Returns Performance 3 |
Profits based on simulation Last Close 11/27/2024 | Upturn Advisory Performance 3 |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 4.01B USD |
Price to earnings Ratio 40.38 | 1Y Target Price 20 |
Dividends yield (FY) 7.17% | Basic EPS (TTM) 0.42 |
Volume (30-day avg) 2135326 | Beta 1.24 |
52 Weeks Range 11.87 - 19.70 | Updated Date 12/20/2024 |
Company Size Mid-Cap Stock | Market Capitalization 4.01B USD | Price to earnings Ratio 40.38 | 1Y Target Price 20 |
Dividends yield (FY) 7.17% | Basic EPS (TTM) 0.42 | Volume (30-day avg) 2135326 | Beta 1.24 |
52 Weeks Range 11.87 - 19.70 | Updated Date 12/20/2024 |
Earnings Date
Report Date - | When - |
Estimate - | Actual - |
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 14.22% | Operating Margin (TTM) 36.32% |
Management Effectiveness
Return on Assets (TTM) 2.83% | Return on Equity (TTM) 3.46% |
Revenue by Products
Revenue by Products - Current and Previous Year
Valuation
Trailing PE 40.38 | Forward PE 8.71 |
Enterprise Value 6393570247 | Price to Sales(TTM) 5.87 |
Enterprise Value to Revenue 9.34 | Enterprise Value to EBITDA 16.67 |
Shares Outstanding 236587008 | Shares Floating 233175223 |
Percent Insiders 1.18 | Percent Institutions 99.37 |
Trailing PE 40.38 | Forward PE 8.71 | Enterprise Value 6393570247 | Price to Sales(TTM) 5.87 |
Enterprise Value to Revenue 9.34 | Enterprise Value to EBITDA 16.67 | Shares Outstanding 236587008 | Shares Floating 233175223 |
Percent Insiders 1.18 | Percent Institutions 99.37 |
Analyst Ratings
Rating 4.14 | Target Price 14.63 | Buy - |
Strong Buy 8 | Hold 6 | Sell - |
Strong Sell - |
Rating 4.14 | Target Price 14.63 | Buy - | Strong Buy 8 |
Hold 6 | Sell - | Strong Sell - |
AI Summarization
Sabra Healthcare REIT Inc.: A Comprehensive Overview
Company Profile:
Detailed history and background:
- Founded in 2010, Sabra Healthcare REIT Inc. (NASDAQ: SBRA) is a Maryland-based Real Estate Investment Trust (REIT) specializing in owning and operating senior housing and skilled nursing facilities across the United States.
- Its portfolio comprises 1,547 properties in 46 states across various care and living arrangements, including skilled nursing, memory care, assisted living, independent living, and outpatient medical facilities.
- As of June 30, 2023, its portfolio accounted for over 98,000 beds and units, making it one of the largest healthcare REITs globally.
Description of the company's core business areas:
- Acquiring and developing healthcare real estate
- Leasing its properties to long-term healthcare operators
- Generating revenue through rental payments from tenants
Overview of the leadership team and corporate structure:
- Chief Executive Officer: Rick Matros
- President and Chief Operating Officer: Talya Nevo-Hacohen
- Executive Vice President, Chief Investment Officer: John J. Ortalano
- Board of Directors of nine members with extensive experience in finance, healthcare, and real estate.
Top Products and Market Share:
Top products and offerings:
- Portfolio of diversified healthcare real estate, including:
- Skilled Nursing Facilities
- Memory Care Facilities
- Assisted Living Facilities
- Independent Living Facilities
- Outpatient Medical Facilities
Market share:
- In the U.S. market, Sabra ranks among the top healthcare REITs based on the number of owned properties and number of beds/units.
- Global market share information for individual companies like Sabra is scarce due to data availability limitations. However, according to NAREIT, all U.S. healthcare REITs collectively owned 4% of the nation's senior housing.
Product performance and market reception compared to competitors:
- Sabra offers a diversified and geographically dispersed portfolio, attracting long-term tenants and generating stable rental income. However, the COVID-19 pandemic negatively impacted the health care and REIT industry, and occupancy rates decreased significantly.
- Compared to its competitors such as Welltower Inc. (WELL) and Ventas Inc. (VTR), Sabra exhibits
- lower net lease exposure but a larger proportion of senior housing operators with lower credit ratings.
Total Addressable Market:
Market size:
- The US senior housing market reached an estimated USD 89.96 billion in 2020 and is projected to expand at a CAGR of 5.4% throughout the 2022–2027 period. This represents a considerable portion of the global USD 649.5 billion market size for senior housing in 2022.
- As the population ages and demands for specialized care increases, the future of healthcare REITs like Sabra appears promising.
Financial Performance:
Recent financial statements analysis:
- Revenue (2020): USD 643.62 million
- Net income (2020): USD 29.6 million
- Profit margins: Profit margin remains slim at 3.4%.
- Earnings per share (EPS): -USD 0.79 (negative due to significant writedowns in 2020)
Financial performance comparison (y-o-y):
- Revenue (2022): USD 1.53 billion, exhibiting strong growth compared to 2020 but still reflecting pandemic recovery.
- Profit and EPS still fluctuating: Net income and EPS in 2022 haven't been reported yet, highlighting the continuing volatility in the healthcare REIT landscape.
Review of cash flow statements and balance sheet health:
- Debt structure:
While Sabra's debt grew through various mergers and acquisitions, the REIT maintains sufficient liquidity from its operating cash flow to address debt obligations. However, investors should carefully monitor future debt management activities.
Dividends and Shareholder Returns:
Dividend History:
- Sabra has a record of paying quarterly dividends, though historically, these haven't been consistently maintained due to fluctuating earnings. **In 2021 and 2022, dividends were suspended. **
Shareholder Returns:
- Negative shareholder returns over the past year due to market uncertainties and economic impacts on the healthcare sector.
Growth Trajectory:
Historical growth analysis (5-10 years):
* Steady overall growth in portfolio size
* Challenges remain regarding improving profit margins and achieving dividend distribution sustainability.
- Acquisition strategy has played a major role in portfolio expansion but has also inflated debt.
Future growth projections:
- Aging demographics favor future demand for senior healthcare facilities.
- Increased investments in technology and operational efficiencies could boost profit margins.
- Success at managing existing debt structure would improve financial stability and attract further investments.
Market Dynamics:
Industry trends & Technological advancements:
- Growing popularity of home-based and alternative senior care models are challenging traditional options like senior housing facilities.
- Tech companies are making inroads towards healthcare automation (e.g., remote care monitoring) which might reshape the demand patterns for skilled care settings.
- Investors are focusing on healthcare REITs' ESG impact and sustainable investing practices.
Company's position and adaptability:
- Sabra operates with a diversified model for different levels of senior care but might need to further expand its lower-acuity portfolio (memory care, independent living) to stay competitive with the evolving preferences.
- The REIT's current debt exposure poses a challenge towards potential investments in technological adaptation initiatives.
Competitors:
- Welltower Inc. (WELL)
- Ventas Inc. (VTR)
- National Health Investors Inc. (NHI)
- Healthcare Trust of America Inc. (HTA)
Competitive advantages and disadvantages:
- Advantages: Diversified portfolio across various care settings, geographically expanded footprint across the US.
- Disadvantages: Debt load weighs on financial flexibility, lack of consistent
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Sabra Healthcare REIT Inc
Exchange | NASDAQ | Headquaters | Tustin, CA, United States |
IPO Launch date | 2002-04-02 | Chairman, President & CEO | Mr. Richard K. Matros |
Sector | Real Estate | Website | https://www.sabrahealth.com |
Industry | REIT - Healthcare Facilities | Full time employees | 48 |
Headquaters | Tustin, CA, United States | ||
Chairman, President & CEO | Mr. Richard K. Matros | ||
Website | https://www.sabrahealth.com | ||
Website | https://www.sabrahealth.com | ||
Full time employees | 48 |
As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities ("Senior Housing - Leased"), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements ("Senior Housing - Managed"), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures. As of September 30, 2023, Sabra's real estate properties held for investment included 37,606 beds/units, spread across the United States and Canada.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.